Clifford Swan Investment Counsel LLC Sells 19,450 Shares of Corteva, Inc. $CTVA

Clifford Swan Investment Counsel LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA) by 3.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 498,309 shares of the company’s stock after selling 19,450 shares during the period. Corteva comprises 1.1% of Clifford Swan Investment Counsel LLC’s holdings, making the stock its 23rd biggest holding. Clifford Swan Investment Counsel LLC owned approximately 0.07% of Corteva worth $33,402,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new position in Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC bought a new position in Corteva in the 3rd quarter worth about $29,000. Jackson Grant Investment Advisers Inc. grew its stake in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares in the last quarter. Basepoint Wealth LLC bought a new position in Corteva in the 4th quarter worth about $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new position in Corteva in the 3rd quarter worth about $33,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Down 0.4%

Shares of NYSE CTVA opened at $77.49 on Friday. The company’s 50-day simple moving average is $81.27 and its 200-day simple moving average is $74.92. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63. The firm has a market cap of $51.82 billion, a price-to-earnings ratio of 45.58, a price-to-earnings-growth ratio of 2.38 and a beta of 0.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business earned $1.13 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analysts Set New Price Targets

A number of brokerages have commented on CTVA. Argus upped their target price on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Citigroup increased their target price on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Berenberg Bank increased their target price on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Finally, UBS Group raised their price target on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $88.67.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.